Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism
(Q83916009)
scientific article published on 05 June 2006
scientific article published on 05 June 2006
Language:
Current Data About
Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism
other details
| description | scientific article published on 05 June 2006 |
External Links
| (P356) |
10.1016/J.VPH.2005.11.011
|
| (P698) |
16750656
|